Results suggest that any kind of interaction to access information while driving has an impact on the driver׳s attention based on a decrease in driving performance and increase of cognitive load.
Here we borrow the concept of "knockout" to describe our in silico experiments of deleting a certain interaction to access its contribution on the dynamics of the system.
Thus, key questions regarding the mechanism of substrate phosphorylation include understanding how docking interactions control the rate of access of phosphorylation sites to the active site, what steps control and limit catalysis and what, if any general features substrates possess.
Key questions regarding the mechanism of substrate phosphorylation address our understanding of how docking interactions control the rate of access of phosphorylation sites to the active site, what steps control and limit catalysis and what, if any, general features do substrates possess?
Data from individual interviews with women who had sustained SPT is used to provide greater insight into their interactions with, and ease of access to, health service providers in NSW.
Data from individual interviews with twelve women who had experienced SPT during vaginal birth is used to provide greater insight into their interactions with, and ease of access to, health service providers in NSW.
Route management covers (i) the definition of the route, (ii) interaction management by means of access reservation and intersection management, (iii) the control of each vehicle to match the particular conditions of the run.
Recent progress in identifying the nature of sphingolipids recognition for iNKT cells in immunity and the functional consequences of the lipid-CD1d interaction opens new avenues of access to the pathogenesis of demyelination in MS as well as design of lipid antigen-specific therapeutics.
The higher TG values associated with H2 haplotype in the SHS may be due an interaction with the lack of access to medications that can control lipids (Stern 1998) and genotype.
In addition, collaborations between academia, biotech, and pharma industrial partners must be facilitated at early development stages to produce new levels of interactions and access to mutual, shared expertise".
